# GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL

> **NCT03884205** · — · UNKNOWN · sponsor: **Shandong Provincial Hospital** · enrollment: 120 (estimated)

## Conditions studied

- PTCL
- Gemcitabine

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03884205
- **Lead sponsor:** Shandong Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-09-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03884205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03884205, "GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03884205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*